Reuters logo
BRIEF-Panacea Biotec Says U.S. FDA Accepts Co's Marketing Application For Generic Cancer Drug
November 30, 2017 / 4:41 AM / 12 days ago

BRIEF-Panacea Biotec Says U.S. FDA Accepts Co's Marketing Application For Generic Cancer Drug

Nov 30 (Reuters) - Panacea Biotec Ltd:

* SAYS U.S. FDA ACCEPTS CO'S ANDA FOR PACLITAXEL PROTEIN BOUND PARTICLES Source text: bit.ly/2BnVN02 Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below